2025 HCPCS Code J7626
Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg
TAGS: inhalation administered final through| Short Description | Budesonide non-comp unit |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Code Added Date | January 01, 2002 |
| HCPCS Action Effective Date | January 01, 2007 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- J1630 - Haloperidol injection
- J1631 - Haloperidol decanoate inj
- J1632 - Inj., brexanolone, 1 mg
- J1640 - Hemin, 1 mg
- J1642 - Inj heparin sodium per 10 u
- J1643 - Inj heparin, pfizer, 1000u
- J1644 - Inj heparin sodium per 1000u
- J1645 - Dalteparin sodium
- J1650 - Inj enoxaparin sodium
- J1652 - Fondaparinux sodium
- J1655 - Tinzaparin sodium injection
- J1670 - Tetanus immune globulin inj
- J1675 - Histrelin acetate
- J1700 - Hydrocortisone acetate inj
- J1710 - Hydrocortisone sodium ph inj
- J1720 - Hydrocortisone sodium succ i
- J1725 - Hydroxyprogesterone caproate
- J1726 - Makena, 10 mg
- J1729 - Inj hydroxyprogst capoat nos
- J1730 - Diazoxide injection